What does PHARMACIE BAYNA do?

PHARMACIE BAYNA is a pharmacy in Sint-Gillis (bij-Brussel). Private Limited, started on 14 January 1999, 1 establishment.

What is the address of PHARMACIE BAYNA?

The registered office of PHARMACIE BAYNA is located at Waterlose Steenweg 114, 1060 Sint-Gillis (bij-Brussel).

Is PHARMACIE BAYNA still active?

Yes. According to the CBE (18 September 2026) PHARMACIE BAYNA is active, legal situation “Normale toestand”, started on 14 January 1999.

Is PHARMACIE BAYNA registered on Peppol?

Yes, PHARMACIE BAYNA is registered on the Peppol network with ID 0208:0465247434.

What is the enterprise number of PHARMACIE BAYNA?

The enterprise number of PHARMACIE BAYNA is BE0465247434.

When was PHARMACIE BAYNA founded?

PHARMACIE BAYNA was founded on 14 January 1999.

Is PHARMACIE BAYNA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 January 1999; 4 annual accounts filed, latest fiscal year 2024.

How much profit did PHARMACIE BAYNA make in 2024?

PHARMACIE BAYNA posted a profit after taxes of € 35,409 in financial year 2024.

What is the revenue of PHARMACIE BAYNA?

As a small company, PHARMACIE BAYNA is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 186,894.

PHARMACIE BAYNA (Private Limited) - Sint-Gillis (bij-Brussel)

Dossier PHARMACIE BAYNA, printed on 18 September 2026 from databakkes.be/en/0465247434/pharmacie-bayna. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 55 % of short-term debt in 2024; threshold 65 %.

Financials

Financial year 2024

PHARMACIE BAYNA from Sint-Gillis (bij-Brussel), company number BE0465247434, closed financial year 2024 with a result of € 35,409 after tax. For that financial year PHARMACIE BAYNA recorded a gross margin of € 186,894 and equity of € 393,424. Compared with financial year 2023, the result moved from € 29,705 to € 35,409. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2025.

What it is worth Growing

€ 393,424

▲ 10% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 35,409

▲ 19% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 56,031

▲ 3% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 374,832.

People and assets in 2024

Vehicles and equipment

€ 13,682

▼ 34% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 125,231

▼ 16% vs 2023

€ 24,446 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 97,525

▲ 8% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 130,337

▲ 11% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 162,090 Gross margin 2021: € 162,090 First fiscal year in the series	€ 154,898 Gross margin 2022: € 154,898 ▼ 4% vs 2021 (€ 162,090) Unfavourable step	€ 201,881 Gross margin 2023: € 201,881 ▲ 30% vs 2022 (€ 154,898) Favourable step	€ 186,894 Gross margin 2024: € 186,894 ▼ 7% vs 2023 (€ 201,881) Unfavourable step	▼ 7%
Profit after taxes	€ 22,851 Profit after taxes 2021: € 22,851 First fiscal year in the series	€ -45,538 Profit after taxes 2022: € -45,538 ▼ € 68,389 vs 2021 (€ 22,851) Unfavourable step	€ 29,705 Profit after taxes 2023: € 29,705 ▲ € 75,243 vs 2022 (€ -45,538) Favourable step	€ 35,409 Profit after taxes 2024: € 35,409 ▲ 19% vs 2023 (€ 29,705) Favourable step	▲ 19%
Equity	€ 373,847 Equity 2021: € 373,847 First fiscal year in the series	€ 328,309 Equity 2022: € 328,309 ▼ 12% vs 2021 (€ 373,847) Unfavourable step	€ 358,015 Equity 2023: € 358,015 ▲ 9% vs 2022 (€ 328,309) Favourable step	€ 393,424 Equity 2024: € 393,424 ▲ 10% vs 2023 (€ 358,015) Favourable step	▲ 10%
Total debts	€ 532,276 Total debts 2021: € 532,276 First fiscal year in the series	€ 509,872 Total debts 2022: € 509,872 ▼ 4% vs 2021 (€ 532,276) Favourable step	€ 420,954 Total debts 2023: € 420,954 ▼ 17% vs 2022 (€ 509,872) Favourable step	€ 355,192 Total debts 2024: € 355,192 ▼ 16% vs 2023 (€ 420,954) Favourable step	▼ 16%
Cash	€ 24,203 Cash 2021: € 24,203 First fiscal year in the series	€ 12,247 Cash 2022: € 12,247 ▼ 49% vs 2021 (€ 24,203) Unfavourable step	€ 54,489 Cash 2023: € 54,489 ▲ € 42,242 vs 2022 (€ 12,247) Favourable step	€ 56,031 Cash 2024: € 56,031 ▲ 3% vs 2023 (€ 54,489) Favourable step	▲ 3%
Land & buildings	€ 160,802 Land & buildings 2021: € 160,802 First fiscal year in the series	€ 153,347 Land & buildings 2022: € 153,347 ▼ 5% vs 2021 (€ 160,802) Unchanged	€ 145,892 Land & buildings 2023: € 145,892 ▼ 5% vs 2022 (€ 153,347) Unchanged	€ 138,438 Land & buildings 2024: € 138,438 ▼ 5% vs 2023 (€ 145,892) Unchanged	▼ 5%
Retained profit	€ 355,255 Retained profit 2021: € 355,255 First fiscal year in the series	€ 309,717 Retained profit 2022: € 309,717 ▼ 13% vs 2021 (€ 355,255) Unfavourable step	€ 339,423 Retained profit 2023: € 339,423 ▲ 10% vs 2022 (€ 309,717) Favourable step	€ 374,832 Retained profit 2024: € 374,832 ▲ 10% vs 2023 (€ 339,423) Favourable step	▲ 10%
Bank debt	€ 161,561 Bank debt 2021: € 161,561 First fiscal year in the series	€ 171,827 Bank debt 2022: € 171,827 ▲ 6% vs 2021 (€ 161,561) Unfavourable step	€ 148,899 Bank debt 2023: € 148,899 ▼ 13% vs 2022 (€ 171,827) Favourable step	€ 125,231 Bank debt 2024: € 125,231 ▼ 16% vs 2023 (€ 148,899) Favourable step	▼ 16%
Balance sheet total	€ 906,124 Balance sheet total 2021: € 906,124 First fiscal year in the series	€ 838,181 Balance sheet total 2022: € 838,181 ▼ 7% vs 2021 (€ 906,124) Unchanged	€ 778,969 Balance sheet total 2023: € 778,969 ▼ 7% vs 2022 (€ 838,181) Unchanged	€ 748,616 Balance sheet total 2024: € 748,616 ▼ 4% vs 2023 (€ 778,969) Unchanged	▼ 4%

Key figures of PHARMACIE BAYNA, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to PHARMACIE BAYNA?

What happened at PHARMACIE BAYNA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2025 New annual accounts for financial year 2024: profit of € 35,409 (▲ 19% vs 2023). filed late Source: NBB ↗
Jun 29, 2016 New establishment in Sint-Gillis (bij-Brussel). KBO
Jan 14, 1999 Start of the company according to the CBE. KBO

In short

From € 22,851 profit in 2021 to € 35,409 profit in 2024.

Paid € 158,255 in corporate taxes since 2021.

Best year ever: 2024, with € 35,409 profit.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE BAYNA? We notify you, reason included.

Follow PHARMACIE BAYNA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Waterlose Steenweg 114

1060 Sint-Gillis (bij-Brussel)

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0465.247.434

VAT number

BE 0465.247.434

Registered office

Waterlose Steenweg 114, 1060 Sint-Gillis (bij-Brussel)

Names & denominations

PHARMACIE BAYNA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

14 January 1999

Peppol

Active · Active since 16 Mar 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗